Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

34 trials with published results (14%)

Research Maturity

166 completed trials (68% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.9%

7 terminated out of 243 trials

Success Rate

96.0%

+9.4% vs benchmark

Late-Stage Pipeline

12%

28 trials in Phase 3/4

Results Transparency

20%

34 of 166 completed with results

Key Signals

34 with results96% success

Data Visualizations

Phase Distribution

185Total
Not Applicable (132)
Early P 1 (2)
P 1 (12)
P 2 (11)
P 3 (20)
P 4 (8)

Trial Status

Completed166
Unknown21
Recruiting20
Active Not Recruiting13
Not Yet Recruiting9
Terminated7

Trial Success Rate

96.0%

Benchmark: 86.5%

Based on 166 completed trials

Clinical Trials (243)

Showing 20 of 20 trials
NCT07735481Not ApplicableNot Yet RecruitingPrimary

Promoting Recovery by Overcoming Self-stigma in Mental Health Disorders With a Narrative Enhancement and Cognitive Therapy (NECT) Group Intervention

NCT04606966Not ApplicableCompleted

Physiological Mechanisms of Therapeutic Horseback Riding Intervention Effects in a Psychiatric Population of ASD Youth

NCT02793271Not ApplicableCompletedPrimary

Reducing Stigma Among Healthcare Providers to Improve Mental Health Services

NCT05206188Not ApplicableActive Not RecruitingPrimary

Mastering the World of Work (MWW): RCT

NCT06673966Recruiting

Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia

NCT05508789Phase 3Active Not Recruiting

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

NCT07704619Not ApplicableNot Yet RecruitingPrimary

Co-Creation Workshops With MaKey MaKey to Promote Participation Among People With Mental Health Conditions

NCT06511908Phase 2Recruiting

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

NCT05318976Phase 2Completed

A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation

NCT05854160Not ApplicableRecruiting

Stimulation-Induced Changes in Fronto-Limbic Network

NCT05738486Phase 3Active Not Recruiting

A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)

NCT06614842Not ApplicableWithdrawn

Common Factors Group Psychotherapy for General Mental Health Concerns

NCT07655063Not ApplicableNot Yet RecruitingPrimary

The Green Room: Virtual Nature for Mental Well-being in the Acute Psychiatry Ward

NCT05824234Not ApplicableRecruitingPrimary

Implementation of REFOCUS Training Program in Mental Health Services

NCT07641244Not ApplicableRecruiting

Experimental Evidence of the Impact of Parental Income on Child Mental Health and Neuroimmune Function

NCT07643714Not ApplicableCompleted

Effects of ACT-Based Psychoeducation on Caregivers of Individuals With Mental Disorders

NCT07387757Not ApplicableCompletedPrimary

Exergames in Mental Health

NCT07581158Not ApplicableNot Yet Recruiting

Understanding and Targeting Self-Regulatory Control in Bulimia Nervosa

NCT03887559Not ApplicableRecruiting

Group-based Stabilization and Skill Training for Patients With Lasting Posttraumatic Reactions in Mental Health Care

NCT05989646Not ApplicableRecruiting

Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children

Scroll to load more

Research Network

Activity Timeline